|
|
3260 Hillview Avenue, Suite 100
Palo Alto, CA 94304 USA
phone:650.493.4200
fax:650.493.4201
|
|
| Symbol |
Private |
| Founded |
2003 |
| Employees |
|
|
|
| www.percsys.com
|
|
| Research Sector |
Medical Devices & Tech |
|
 |
| Summary Description |
| Stone Management Device for Urological Applications |
|
| Management |
| Robert Behl - CEO,
Craig Ball - VP Marketing |
| |
|
|
| |
|
| Keywords |
| Urologic, Urology, kidney stones, ureteral stones, stone management, endoscopic devices, catheters, advamed |
|
|
|
| Description |
|
The mission of Percutaneous Systems, Inc. (PercSys) is to develop devices that make urologic and endoscopic procedures easier, less traumatic and more effective therapeutically. While its current devices influence outcomes of procedures performed in the operating room, devices in the pipeline will help move procedures from the hospital into the office environment. |
|
| Products / Services |
In June 2007, the company released the 7mm PercSys Accordion Stone Management Device, which was ideal for use in stone procedures in the lower and middle ureter. PercSys added a 10mm version of the device to the Accordion family in March 2008. This larger device was designed to occlude the upper ureter in order to prevent stone/fragment migration in both ureteroscopic and percutaneous nephrolithotomy (PCNL) stone procedures.
|
|
| Technology / Differentiation |
| The PercSys Accordion Stone Management Device can be used to entrap and remove stones and other foreign objects from the ureter. The device combines the attributes of multiple endoscopic stone management tools into a single device. The Accordion device tracks past the stone like a guidewire and can be monitored with fluoroscopic or endoscopic imaging. Once formed, the device's film occlusion conforms to and fills the ureter and is designed to prevent retrograde migration of stone fragments. During stone fragmentation, the Accordion device facilitates distal rinsing of smaller fragments in order to keep the field of view clear. Following fragmentation, the device can sweep larger fragments into the bladder or a ureteral access sheath, thereby eliminating the tedious and often time-consuming serial basketing of individual fragments. These benefits combine to simplify endoscopic lithotripsy procedures. |
|
| Market / Customers |
Approximately 5 percent of Americans will be affected by urinary stones at some point in their lives. The incidence of a kidney stone is among the most painful and prevalent of urologic disorders; If a stone becomes large enough, it can block or otherwise create pressure, pain, and infection in the kidney or ureter.
|
|
| Status |
| PercSys is in the midst of driving a five-year series of unique product introductions for urology. The company's first product was introduced in mid-2007 at the American Urological Association (AUA) meeting and the second product release coincided with the AUA's 2008 meeting. The introduction of a third device is expected prior to AUA 2009. With over 1000 successful stone interventions complete, PercSys currently is in market development in limited geographies and plans a full-scale commercial launch in mid-2009. |
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members